Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich pentatricopeptide repeat containing pseudogene (ENSG00000258505, LOC100420765) is annotated as a pseudogene in the human genome. It is related by sequence homology to the protein-coding gene LRPPRC, which encodes a mitochondrial protein involved in RNA processing and mitochondrial gene expression[1][3][5]. Pseudogenes like this one arise through genome duplication or retrotransposition events and typically accumulate mutations that prevent them from producing functional proteins[2][4]. While some pseudogenes exhibit partial or regulatory RNA activity, there is no evidence that this specific pseudogene encodes any functional protein or plays a direct biological or disease-related role. As a result, it is not considered a therapeutic target and is not of direct relevance for drug discovery or clinical biomarker application[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich pentatricopeptide repeat containing pseudogene.